IN2012DN00899A - - Google Patents
Info
- Publication number
- IN2012DN00899A IN2012DN00899A IN899DEN2012A IN2012DN00899A IN 2012DN00899 A IN2012DN00899 A IN 2012DN00899A IN 899DEN2012 A IN899DEN2012 A IN 899DEN2012A IN 2012DN00899 A IN2012DN00899 A IN 2012DN00899A
- Authority
- IN
- India
- Prior art keywords
- culture system
- cell culture
- cell
- continuous
- less
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M3/00—Tissue, human, animal or plant cell, or virus culture apparatus
- C12M3/006—Cell injection or fusion devices
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0056—Xeno-free medium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6489—Metalloendopeptidases (3.4.24)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/98—Xeno-free medium and culture conditions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/00051—Methods of production or purification of viral material
- C12N2710/00052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/24—Metalloendopeptidases (3.4.24)
- C12Y304/24087—ADAMTS13 endopeptidase (3.4.24.87)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Sustainable Development (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
Described herein is a chemostat-like continuous cell culture system that combines certain advantages of perfusion open systems and chemostat open systems to improve the culturing of mammalian cells, e.g., genetically modified cells, particularly in serum-free or chemically-defined media. The continuous culture system described herein involves culturing mammalian cells in a continuous cell culture system, which comprises a cell retention device, wherein the cell culture system has a dilution rate (D) of less than about 2 d-1, and a cell density of less than about 2X107cell/mL. Also described herein is a method for producing a polypeptide and/or virus of interest in a continuous cell culture, the method comprising culturing mammalian cells expressing the polypeptide and/or virus of interest in a continuous cell culture system, which comprises a cell retention device, wherein the cell culture system has a dilution rate (D) of less than about 2d-1, and a cell density of less than about 2X107 cell/mL; and recovering the polypeptide and/or virus of interest from medium of the cell culture system.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23031309P | 2009-07-31 | 2009-07-31 | |
PCT/EP2010/061191 WO2011012725A1 (en) | 2009-07-31 | 2010-08-02 | Method of producing a polypeptide or virus of interest in a continuous cell culture |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012DN00899A true IN2012DN00899A (en) | 2015-04-03 |
Family
ID=42668436
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN899DEN2012 IN2012DN00899A (en) | 2009-07-31 | 2010-08-02 |
Country Status (22)
Country | Link |
---|---|
US (4) | US8580554B2 (en) |
EP (2) | EP3480292A1 (en) |
JP (2) | JP5808742B2 (en) |
KR (2) | KR101752789B1 (en) |
CN (1) | CN102549142B (en) |
AU (1) | AU2010277490B2 (en) |
BR (1) | BR112012002137B8 (en) |
CA (1) | CA2769354A1 (en) |
CO (1) | CO6491119A2 (en) |
DK (1) | DK2459697T3 (en) |
EA (1) | EA022219B1 (en) |
ES (1) | ES2705206T3 (en) |
HR (1) | HRP20182165T1 (en) |
IN (1) | IN2012DN00899A (en) |
MX (2) | MX2012001274A (en) |
NZ (1) | NZ597742A (en) |
PL (1) | PL2459697T3 (en) |
PT (1) | PT2459697T (en) |
SG (1) | SG178176A1 (en) |
SI (1) | SI2459697T1 (en) |
TR (1) | TR201900213T4 (en) |
WO (1) | WO2011012725A1 (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103097522A (en) | 2010-07-08 | 2013-05-08 | 巴克斯特国际公司 | Method of producing recombinant ADAMTS13 in cell culture |
EP3626737B1 (en) * | 2011-05-13 | 2023-11-29 | Octapharma AG | A method of increasing the productivity of eucaryotic cells in the production of recombinant fviii |
WO2013006479A2 (en) | 2011-07-01 | 2013-01-10 | Amgen Inc. | Mammalian cell culture |
CN203129697U (en) | 2013-02-05 | 2013-08-14 | 客贝利(厦门)休闲用品有限公司 | Tent frame pole |
CN109097398A (en) | 2011-11-24 | 2018-12-28 | 吉尼松公司 | The compatible slow virus carrier production system amplified is applied with industrial pharmaceutical |
US9574167B2 (en) | 2013-02-15 | 2017-02-21 | Pharyx, Inc. | Methods and apparatus for independent control of product and reactant concentrations |
AU2014226126B2 (en) | 2013-03-08 | 2019-02-14 | Genzyme Corporation | Continuous purification of therapeutic proteins |
US9217168B2 (en) | 2013-03-14 | 2015-12-22 | Momenta Pharmaceuticals, Inc. | Methods of cell culture |
US10316282B2 (en) | 2013-03-19 | 2019-06-11 | Cmc Biologics A/S | Method for producing a product (e.g. polypeptide) in a continuous cell culture fermentation process |
CN105473712B (en) * | 2013-08-30 | 2022-05-27 | 葛兰素史密丝克莱恩生物有限公司 | Large scale production of viruses in cell culture |
US11390663B2 (en) | 2013-10-11 | 2022-07-19 | Regeneron Pharmaceuticals, Inc. | Metabolically optimized cell culture |
TWI709570B (en) | 2014-01-17 | 2020-11-11 | 美商健臻公司 | Sterile chromatography and manufacturing processes |
TWI709569B (en) | 2014-01-17 | 2020-11-11 | 美商健臻公司 | Sterile chromatography resin and use thereof in manufacturing processes |
AU2015240353A1 (en) | 2014-04-01 | 2016-11-17 | Advantech Bioscience Farmaceutica Ltda. | Stable Factor VIII formulations with low sugar-glycine |
WO2015149144A2 (en) | 2014-04-01 | 2015-10-08 | Advantech Bioscience Farmacêutica Ltda. | Stabilization of factor viii without calcium as an excipient |
CN106414719B (en) * | 2014-06-13 | 2020-02-14 | 杰特有限公司 | Improved production of recombinant von Willebrand factor in a bioreactor |
EP3408371A1 (en) * | 2016-01-26 | 2018-12-05 | Boehringer Ingelheim International Gmbh | Linked perfusion to continuous-flow stirred-tank reactor cell culture system |
KR102414290B1 (en) * | 2016-04-15 | 2022-06-29 | 베링거 인겔하임 인터내셔날 게엠베하 | Cell retention devices and methods |
US20200063086A1 (en) * | 2016-12-21 | 2020-02-27 | Hoffmann-La Roche Inc. | Growth control of eukaryotic cells |
WO2019239780A1 (en) * | 2018-06-15 | 2019-12-19 | 富士フイルム株式会社 | Cell culture method, cell culture device, and method for producing product |
EP3843869A1 (en) | 2018-08-31 | 2021-07-07 | Genzyme Corporation | Sterile chromatography resin and use thereof in manufacturing processes |
CN113355297A (en) * | 2021-06-23 | 2021-09-07 | 吉林冠界生物技术有限公司 | Method for producing recombinant avian influenza virus by perfusion culture of full-suspension MDCK cells |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5019512A (en) | 1989-03-17 | 1991-05-28 | Baxter International Inc. | Spin filter for removing substantially cell-free culture medium from suspension cell culture system |
US5626734A (en) | 1995-08-18 | 1997-05-06 | University Technologies International, Inc. | Filter for perfusion cultures of animal cells and the like |
HUP0301245A3 (en) | 2000-10-02 | 2005-12-28 | Novo Nordisk Healthcare Ag | Tmethod for the production of vitamin k-dependent proteins |
HUP0402226A2 (en) * | 2001-11-28 | 2005-02-28 | Sandoz Ag. | Cell culture process |
US7294484B2 (en) | 2004-08-27 | 2007-11-13 | Wyeth Research Ireland Limited | Production of polypeptides |
ATE544866T1 (en) | 2005-06-17 | 2012-02-15 | Baxter Int | COMPOSITIONS CONTAINING ADAMTS13 WITH THROMBOLYTIC ACTION |
ES2474573T3 (en) | 2006-01-04 | 2014-07-09 | Baxter International Inc | Cell culture medium without oligopeptides |
EP2574676B1 (en) * | 2007-12-27 | 2017-08-30 | Baxalta GmbH | Cell culture processes |
-
2010
- 2010-07-30 US US12/847,921 patent/US8580554B2/en active Active
- 2010-08-02 PT PT10737916T patent/PT2459697T/en unknown
- 2010-08-02 EP EP18199855.0A patent/EP3480292A1/en not_active Withdrawn
- 2010-08-02 EP EP10737916.6A patent/EP2459697B1/en active Active
- 2010-08-02 JP JP2012522190A patent/JP5808742B2/en active Active
- 2010-08-02 PL PL10737916T patent/PL2459697T3/en unknown
- 2010-08-02 IN IN899DEN2012 patent/IN2012DN00899A/en unknown
- 2010-08-02 TR TR2019/00213T patent/TR201900213T4/en unknown
- 2010-08-02 EA EA201270213A patent/EA022219B1/en not_active IP Right Cessation
- 2010-08-02 CA CA2769354A patent/CA2769354A1/en not_active Abandoned
- 2010-08-02 NZ NZ597742A patent/NZ597742A/en unknown
- 2010-08-02 AU AU2010277490A patent/AU2010277490B2/en active Active
- 2010-08-02 DK DK10737916.6T patent/DK2459697T3/en active
- 2010-08-02 MX MX2012001274A patent/MX2012001274A/en active IP Right Grant
- 2010-08-02 ES ES10737916T patent/ES2705206T3/en active Active
- 2010-08-02 BR BR112012002137A patent/BR112012002137B8/en active IP Right Grant
- 2010-08-02 KR KR1020127004996A patent/KR101752789B1/en active IP Right Grant
- 2010-08-02 SI SI201031835T patent/SI2459697T1/en unknown
- 2010-08-02 WO PCT/EP2010/061191 patent/WO2011012725A1/en active Application Filing
- 2010-08-02 SG SG2012006599A patent/SG178176A1/en unknown
- 2010-08-02 KR KR1020177017512A patent/KR101885046B1/en active IP Right Grant
- 2010-08-02 CN CN201080036754.2A patent/CN102549142B/en active Active
-
2012
- 2012-01-27 MX MX2014008515A patent/MX353610B/en unknown
- 2012-02-06 CO CO12020130A patent/CO6491119A2/en unknown
-
2013
- 2013-10-10 US US14/050,710 patent/US9650612B2/en active Active
-
2015
- 2015-01-14 JP JP2015004718A patent/JP6177260B2/en active Active
-
2017
- 2017-04-12 US US15/486,181 patent/US10221400B2/en active Active
-
2018
- 2018-12-20 HR HRP20182165TT patent/HRP20182165T1/en unknown
-
2019
- 2019-01-18 US US16/252,216 patent/US10745672B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2012DN00899A (en) | ||
JP2016105737A5 (en) | ||
JP2015521848A5 (en) | ||
AU2019268194A1 (en) | Cell culture system | |
NZ601424A (en) | Method for the production of ad26 adenoviral vectors | |
NZ602958A (en) | High level expression of recombinant toxin proteins | |
NZ593235A (en) | Method for the production of recombinant adenovirus serotype 35 | |
ATE488600T1 (en) | PRODUCT QUALITY IMPROVEMENT IN MAMMAL CELL CULTURE PROCESSES FOR PROTEIN PRODUCTION | |
MX2009011805A (en) | Improvement of factor viii polypeptide titers in cell cultures. | |
WO2007015848A3 (en) | Improved methods and compositions for increasing longevity and protein yield from a cell culture | |
WO2001051616A3 (en) | Techniques for growth and differentiation of human pluripotent stem cells | |
NZ586250A (en) | Cell culture processes | |
EA201270469A1 (en) | METHODS OF CULTIVATION OF MAMMALIAN CELLS FOR PROTEIN | |
MX353489B (en) | Method of producing erythrocytes without feeder cells. | |
WO2008090770A1 (en) | Microorganism capable of producing l-amino acid, and method for production of l-amino acid | |
WO2007088372A3 (en) | Cell culture | |
JP2013510570A5 (en) | ||
MX338560B (en) | Fusion enzymes having n-acetylglucosaminyltransferase activity. | |
WO2009016078A3 (en) | Method for culturing mammalian stem cells | |
AR084998A1 (en) | FERMENTATION METHOD OF A GASEOUS SUBSTRATE THAT INCLUDES HYDROGEN | |
EP2547761A4 (en) | Method of culturing pancreatic islet-like tissues by a tissue complex of pancreas-derived non-endocrinal epithelial cells and vascular endothelial cells | |
WO2011096750A3 (en) | Method for preparing recombinant glycoproteins with high sialic acid content | |
EP4353743A3 (en) | A method of increasing the productivity of eucaryotic cells in the production of recombinant fviii | |
MX2020013633A (en) | Methods of producing recombinant proteins. | |
WO2010115634A8 (en) | Method for improved single cell cloning |